Table 5.

The outcome of patients infected with SARS-CoV-2 (N = 492).

	Patients with AKI	Patients without AKI	p value
Hospital stay (d)	11 (7-14)	10 (7-14)	0.46
Hospitalization expenses (yuan)	15500.73 (7170.23-40778.82)	7353.37 (4657.50-11578.42)	<0.001
Clinical outcome
Death	23 (63.9%)	52 (11.4%)	<0.001
Discharge	11 (30.56%)	390 (85.5%)
Transferring	2 (5.6%)	14 (3.1%)

Data are median (IQR), or n/N (%), where N is the total number of patients with available data. p values comparing patients with AKI and without AKI are from chi-square or Mann–Whitney U test. SARS-CoV-2 = 2019 novel coronavirus; AKI = acute kidney injury.